Trial Profile
Phase I trial of NP213 in patients with onychomycosis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Jan 2016
Price :
$35
*
At a glance
- Drugs NP 213 (Primary)
- Indications Onychomycosis
- Focus Adverse reactions
- Sponsors NovaBiotics
- 20 Jan 2016 New trial record